Targeting tankyrase scaffolding in the β-catenin destruction complex by PROTAC overcomes the limitation of catalytic inhibitors in colorectal cancer
Aberrant WNT/β-catenin signaling drives tumorigenesis and metastasis in cancer.
Aberrant WNT/β-catenin signaling drives tumorigenesis and metastasis in cancer.